Liquid-Crystalline Supramolecular Polymers
FULL PAPER
708C, 75 MHz): 164.9, 159.9, 151.6, 141.9, 133.7, 132.0, 123.4, 115.7, 114.8,
109.2, 92.3, 88.4, 68.5, 47.9, 29.2, 29.1, 26.3, 25.9, 12.5 ppm; FTIR (an-
nealed film on CaF2): n˜ =3164, 3039, 2935, 2857, 2215, 1684, 1653, 1602,
1518, 1469, 1354, 1283, 1244, 1173 cmꢀ1; UV: lmax =274, 332, 353, 383 nm;
photoluminescence (excitation at 340 nm, CHCl3): 366, 384; DSC (Tm =
2158C); MS (MALDI-TOF): m/z: 726 [M+].
(t, 2H; NCH2), 3.35 (s, 3H; T-NCH3), 1.92 (s, 3H; T-CH3), 1.84–1.65 (m,
4H; OCH2CH2 and NCH2CH2), 1.61–1.35 ppm (m, 4H; 2alkyl CH2);
13C NMR (CDCl3, 75 MHz): d=159.2, 138.4, 117.2, 82.7, 68.3, 34.3, 33.1,
29.6, 29.5, 29.4, 28.9, 28.4, 26.2. 164.2, 159.1, 151.8, 138.4, 117.1, 109.8,
103.6, 82.8, 68.0, 49.7, 29.3, 29.2, 28.2, 26.5, 25.9, 13.4 ppm; MS (MALDI-
TOF): m/z: 443 [M+H]+.
4-(1-Nonyloxy-6-(N3-methyl)-thymine)-1-bis(phenylethynyl)benzene
(TMe1aTMe): In a glove box, 1,4-diethynylbenzene (0.02 g, 0.15 mmol),
TMe4 (0.08 g, 0.34 mmol), [Pd(PPh3)4] (2.00 mg, 1.7110ꢀ6 mol), and CuI
(1.00 mg, 1.7110ꢀ6 mol) were added to a 3:1 v/v mixture of toluene/di-
isopropylamine (7.5 mL). The mixture was then heated to 758C, and stir-
red for 18 h under an argon atmosphere. The solvents of the resulting lu-
minescent suspension were subsequently evaporated. Column chromatog-
raphy (silica gel; 95:5 CH2Cl2/MeOH) of the resulting crude product af-
forded pure TMe1aTMe (0.12 g, 75%). 1H NMR (CDCl3, 300 MHz): d=
7.47 (s, 4H; ArH), 7.46 (d, 4H; ArH), 6.97 (s, 1H; T-CH), 6.86 (d, 4H;
ArH), 3.98 (t, 4H; OCH2), 3.71 (t, 4H; NCH2), 3.37 (s, 6H; T-NCH3),
1.95 (s, 6H; T-CH3), 1.84–1.65 (m, 8H; OCH2CH2 and NCH2CH2), 1.60–
1.35 ppm (m, 8H; 4alkyl CH2); 13C NMR (CDCl3, 75 MHz): d=164.3,
159.4, 151.8, 138.4, 133.4, 132.6, 131.7, 131.6, 124.9, 123.3, 121.25, 115.7,
114.8, 109.8, 91.5, 88.2, 68.0, 49.7, 29.3, 28.2, 26.5, 25.9, 113.4 ppm; FTIR
(annealed film on CaF2): n˜ =3065, 2933, 2858, 2212, 1698, 1664, 1638,
1602, 1519, 1468, 1356, 1284, 1246, 1174 cmꢀ1; UV: lmax =274, 335, 354,
378 nm; photoluminescence (excitation at 330 nm, CHCl3): 366, 383, 397;
DSC (Tm =1548C); MS (MALDI-TOF): m/z: 754 [M+].
N7-Dodecyl-(N6-(4-methoxybenzoyl)adenine (dodecyl-AAn): p-Anisoyl-
adenine (2.33 g, 8.63 mmol) was dissolved in dry DMF (45.0 mL), and
sodium hydride (1.00 g, 41.6 mmol) was added in portions. The mixture
was allowed to stir for 1 h at RT. Bromododecane (3.98 mL, 16.0 mmol)
was then added dropwise by means of a syringe and the mixture was al-
lowed to stir for 5 h at 408C, followed by ~20 h at 308C. Methanol was
added to deactivate any remaining NaH. The solvent was then evaporat-
ed, the residue was dissolved in CH2Cl2 and the organic phase was
washed two times with water. Hexane was then added to the CH2Cl2
fraction and the product precipitated out upon removal of the CH2Cl2.
The precipitate was filtered and reprecipitated again by using the same
procedure. Column chromatography (silica gel; 99:1 CH2Cl2/MeOH) of
the resulting crude product afforded pure dodecyl-AAn as a white solid
(1.50 g, 40%). M.p. 978C; Rf =0.62 (95:5 CH2Cl2/CH3OH); 1H NMR
(CDCl3, 200 MHz): d=8.92 (brs, 1H; NH), 8.80 (s, 1H; adenine H-2),
8.15 (d, 2H; anis-ArH), 8.00 (s, 1H; adenine H-8), 7.02 (d, 2H; anis-
ArH), 4.27 (t, 2H; alkyl 1CH2), 3.89 (s, 3H; anis-OMe), 2.05–1.82 (m,
2H; alkyl 2CH2), 1.42–1.12 (m, 8H; alkyl (3–11)CH2), 0.80–0.95 (t, 3H;
alkyl CH3); 13C NMR (CDCl3, 75 MHz): d=164.5, 163.4, 152.7, 152.3,
142.9, 130.2, 126.2, 123.2, 114.2, 55.7, 44.4, 32.2, 30.2, 29.8, 29.7, 29.6, 29.5,
29.3, 26.9, 22.9, 14.4 ppm; MS (MALDI-TOF): m/z: 439 [M+H]+.
4-(1-Nonyloxy-6-(thymine))-1-bis(phenylethynyl)benzene (T1bT): The re-
action was conducted according to the general procedure described
above, using T4b (2.05 g, 4.36 mmol), and afforded
a yellow solid.
Column chromatography (silica gel; 100:0, 99:1, 98:2 CH2Cl2/MeOH) of
the resulting crude product afforded pure T1bT as a yellow solid (1.02 g,
64%). 1H NMR (CDCl3, 600 MHz): d=8.32 (s, 2H; NH), 7.47 (s, 4H;
ArH), 7.46 (d, 4H; ArH), 6.97 (s, 2H; T-CH), 6.86 (d, 4H; ArH), 3.98 (t,
4H; OCH2), 3.71 (t, 4H; NCH2), 1.93 (s, 6H; T-CH3), 1.84–1.65 (m, 8H;
OCH2CH2 and NCH2CH2), 1.60–1.35 ppm (m, 20H; 10alkyl CH2);
13C NMR (CDCl3, 75 MHz): d=164.5, 159.6, 151.1, 140.7, 133.3, 131.6,
123.4, 115.2, 114.9, 110.8, 91.5, 88.2, 68.3, 48.8, 29.6, 29.5, 29.3, 26.6, 26.2,
12.6 ppm; FTIR (annealed film on CaF2) n˜ =3165, 3037, 2927, 2854, 2215,
1683, 1519, 1486, 1486, 1356, 1246, 1173 cmꢀ1; UV: lmax =281, 333, 353,
377 nm; photoluminescence (excitation at 340 nm, CHCl3): 367, 385;
DSC (Tm =2078C); MS (MALDI-TOF): m/z: 810 [M+].
4-(1-Hexyloxy-6-(N6-(4-methoxybenzoyl)adenine)-1-bis(phenylethynyl)-
benzene (AAn1aAAn): The reaction was conducted according to the gener-
al procedure described above, using AAn4a (2.49 g, 4.36 mmol), and af-
forded a yellow solid. Column chromatography (silica gel; 99:1, 98:2!
95:5 CH2Cl2/MeOH) of the resulting crude product afforded pure
AAn1aAAn as a yellow solid (1.14 g, 57%). 1H NMR (CDCl3, 600 MHz):
d=9.09 (brs, 2H; NH), 8.76 (s, 2H; adenine H-8), 8.01(s, 2H; adenine
H-2), 8.00 (d, 4H; anis-ArH), 7.44 (d, 4H; ArH), 7.43 (s, 4H; ArH), 6.98
(d, 4H; anis-ArH), 6.83 (d, 4H; ArH), 4.27 (t, 4H; NCH2), 3.94 (t, 4H;
OCH2), 3.87 (s, 6H; anis-OCH3), 2.05–1.88 (m, 4H; NCH2CH2), 1.88–
1.65 (m, 4H; OCH2CH2), 1.55–1.25 ppm (m, 8H; 4alkyl CH2);
13C NMR (DMSO at 708C, 75 MHz): d=165.8, 163.3, 159.9, 153.1, 151.9,
150.0, 145.0, 133.7, 132.0, 131.2, 126.7, 125.9, 123.3, 115.7, 114.8, 114.4,
114.5, 92.3, 88.4, 68.5, 56.3, 44.0, 30.2, 29.9, 29.1, 26.5, 25.7 ppm; FTIR
(annealed film on CaF2): n˜ =3411, 3239, 3071, 3041, 2936, 2862, 2214,
1700, 1696, 1685, 1602, 1577, 1517, 1452, 1404, 1306, 1284, 1241, 1171,
1089, 1025 cmꢀ1; UV: lmax =291, 331, 353, 378 nm; photoluminescence
(excitation at 340 nm, CHCl3): 366, 384; DSC (Tm =1888C); MS
(MALDI-TOF): m/z: 1012 [M+].
4-(1-Hexyloxy-6-(N6-(4-methoxybenzoyl)adenine)-1-bis(phenylethynyl)-
benzene (AAn1bAAn): The reaction was conducted according to the gener-
al procedure described above, using AAn4b (2.67 g, 4.36 mmol), and af-
forded a yellow solid. Column chromatography (silica gel; 1:99, 2:98!
4:96 MeOH/CH2Cl2) of the resulting crude product afforded pure
AAn1bAAn as a yellow solid (1.09 g, 50%). 1H NMR (CDCl3, 200 MHz):
d=9.10 (brs, 2H; NH), 8.78 (s, 2H; adenine H-8), 8.00 (d, 4H; anis-
ArH), 7.98 (s, 2H; adenine H-2), 7.45 (d, 4H; ArH), 7.44 (s, 4H; ArH),
6.97 (d, 4H; anis-ArH), 6.85 (d, 4H; ArH), 4.26 (t, 4H; NCH2), 3.95 (t,
4H; OCH2), 3.87 (s, 6H; anis-OCH3), 2.01–1.85 (m, 4H; NCH2CH2),
1.88–1.65 (m, 4H; OCH2CH2), 1.50–1.25 ppm (m, 20H; 10alkyl CH2);
13C NMR (CDCl3, 50 MHz): d=165.7, 164.8, 160.8, 154.0, 153.6, 151.2,
144.3, 134.7, 134.6, 132.8, 131.5, 127.4, 124.6, 124.5, 116.5, 116.1, 115.8,
115.7, 92.8, 89.5, 69.5, 57.0, 45.7, 31.5, 30.8, 30.7, 30.7, 30.5, 28.2,
27.5 ppm; FTIR (annealed film on CaF2): n˜ =3416, 3257, 3071, 3041,
2927, 2854, 2215, 1699, 1684, 1603, 1577, 1517, 1456, 1312, 1284, 1244,
1172, 1090, 1024 cmꢀ1; UV: lmax =290, 332, 352, 378 nm; photolumines-
cence (excitation at 340 nm, CHCl3): 367, 385; DSC (Tm =2028C); MS
(MALDI-TOF): m/z: 1098 [M+].
4-(1-Hexyloxy-6-(N3-methyl)-thymine)-1-iodobenzene (TMe4a): Methyl
iodide (174 ml, 0.28 mmol) was added in one portion to a stirred solution
of DMF (3 mL), K2CO3 (0.19 g, 0.14 mmol), and T4a (0.30 g, 0.70 mmol)
at 608C. After 16 h, the reaction was poured into water and extracted
with CH2Cl2. The combined organic layers were washed with water and
then the CH2Cl2 was evaporated. Column chromatography (silica gel;
99:1 CH2Cl2/MeOH) of the resulting crude product afforded pure TMe4a
(0.27 g, 88%). M.p. 868C; 1H NMR (CDCl3, 300 MHz): d=7.55 (d, 2H;
ArH), 6.96 (s, 1H; T-CH), 6.65 (d, 2H; ArH), 3.91 (t, 2H; OCH2), 3.73
N3-Dodecyl-thymine (dodecyl-T): Thymine (1.00 g, 7.93 mmol) was
added to dry DMF (14 mL), and NaH (0.38 g, 15.8 mmol) was then
added in portions to the mixture. The solution was thermostated at
1008C for 4 h and then allowed to cool to RT. Bromododecane (4.37 mL,
18.2 mmol) was then added dropwise by means of a syringe, and the mix-
ture was allowed to stir for 48 h at 1008C. The reaction mixture was then
removed from the heat and neutralized with ~2 mL of acetic acid. The
solvent was evaporated in vacuo and the residue was dissolved in chloro-
form. Any remaining undissolved material was filtered off and the solu-
ble fraction was then washed with water (100 mL). The separated chloro-
form was then stirred with sodium sulfate for 15 min and filtered.
Hexane was then added to the CH2Cl2 fraction and the product precipi-
tated out upon removal of the CH2Cl2. Column chromatography (silica
gel; 99:1 CH2Cl2/MeOH) of the resulting crude product afforded pure
dodecyl-T as a white solid (0.72 g, 30.7%). M.p. 122.18C; Rf =0.51 (95:5
CH2Cl2/CH3OH); 1H NMR (CDCl3, 200 MHz): d=8.42 (brs, 1H; NH),
1
6.97 (s, 1H; T-CH), 3.70 (t, 2H; alkyl CH2), 1.95 (s, 3H; T-CH3), 1.75–
1.61 (m, 2H; alkyl 2CH2), 1.40–1.21 (m, 8H; alkyl (3–11)CH2), 1.95–
1.85 ppm (m, 3H; alkyl 12CH3); 13C NMR (CDCl3, 50 MHz): d=166.2,
152.7, 142.0, 112,1, 50.1, 33.4, 31.1, 31.0, 30.9, 30.8, 30.7, 28.0, 24.3, 15.7,
14.0 ppm; MS (MALDI-TOF): m/z: 295 [M+H]+.
Chem. Eur. J. 2006, 12, 446 – 456
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
455